Experimental long-term interventions as applied to mice are hardly doable in humans, but pertinent changes in glycemia and insulin sensitivity have been described in association with hematocrit changes caused by altitude, Chuvash polycythemia, and therapeutic administration of rhEPO or testosterone (5, 23–25, 27). The gene discussed is INS; the disease is Chuvash polycythemia.